首页 | 本学科首页   官方微博 | 高级检索  
     

定量PCR-微流芯片法定量检测血清HBV DNA含量
引用本文:黄希田,颜鸣鹤,凌乔,蔡丽敏,曾爱平. 定量PCR-微流芯片法定量检测血清HBV DNA含量[J]. 中国感染控制杂志, 2003, 2(2): 89-91
作者姓名:黄希田  颜鸣鹤  凌乔  蔡丽敏  曾爱平
作者单位:温岭市第一人民医院,感染科,浙江,温岭,317500
摘    要:
目的应用定量PCR-微流芯片法定量检测临床血清标本HBV DNA含量,以了解该方法的灵敏度。方法将定量PCR-微流芯片法应用于10倍梯度稀释的HBV DNA参比品的定量检测,并与Taqman荧光定量法作比较;同时,应用这两种方法平行检测49份HBsAg阳性乙型肝炎患者的血清标本。结果Taqman荧光定量法可检测出104拷贝/mL的HBV DNA参比品,测得临床血清标本HBV DNA阳性率为63.27%(31/49),阳性血清的HBV DNA含量均值为9.60×106±19.54拷贝/mL;而PCR芯片法可测出103拷贝/mL HBV DNA参比品,测得临床血清标本HBV DNA的阳性率为77.55%(38/49),阳性血清的HBV DNA含量均值为6.95×106±15.43拷贝/mL。两者差异无显著性(P>0.05)。结论两种方法均能有效检测临床血清标本HBV DNA含量,而定量PCR一微流芯片法的敏感性更高,尤其适合于低病毒载量检测及患者抗病毒药物选择和疗效的监测。

关 键 词:HBV DNA  Taqman荧光定量PCR  定量PCR-微流芯片法
文章编号:1671-9638(2003)02-0089-03
修稿时间:2002-12-13

Quantitative detection of HBV DNA in human serum by quantitative PCR-fluidic chip assay
HUANG Xi-tian,VAN Ming-he,LING Qiao,CAI Li-min,ZENG Ai-pi ng. Quantitative detection of HBV DNA in human serum by quantitative PCR-fluidic chip assay[J]. Chinese Journal of Infection Control, 2003, 2(2): 89-91
Authors:HUANG Xi-tian  VAN Ming-he  LING Qiao  CAI Li-min  ZENG Ai-pi ng
Abstract:
Objective To explore the quantitative PCR-fluidic chip assay for quantitative detection of HBV DNA in clinical serum samples. Methods A 10-fold series dilution of standard HBV DNA was analyzed by quantitative PCR-fluidic chip, the serum HBV DNA quantification in 49 patients suffering from chronic hepatitis B with positive HBsAg was also detected. The results were compared with the detection of quantitative fluorescence PCR technique. Results The lowest detective value of standard HBV DNA was 104 copies/mL and serum HBV DNA positive rate was 63.27% (31/49), the average concentration of serum HBV DNA was 9. 60 x 106 + 19.54 copies/mL analyzed by the assay of quantitative fluorescence PCR; while the lowest detective value of standard HBV DNA was 10 copies/mL, serum HBV DNA positive rate was 77.55 % (38 /49) and the average concentration of HBV DNA was 6.95 x 10s + 15.43 copies/mL by quantitative PCR-fluidic chip assay. Significant difference was not found between the two methods ( P >0.05). Conclusions The two assays have the same important value in the clinical diagnosis, the quantitative PCR-fluidic chip assay has a higher sensitivity, and may be more suitable for evaluation of the therapeutic selection and efficacy for the patients with HBV infection.
Keywords:HBV DNA  fluorescence quantitative PCR  quantitative PCR-fluidic chip
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号